Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
European Heart Journal
|
January 7, 2017
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy
Constanze Schmidt, Felix Wiedmann, Xiao-Bo Zhou, et al.
Circulation
|
May 9, 2015
Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
Constanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Circulation
|
March 16, 2016
Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation"
Constanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Cardiovascular Research
|
June 11, 2020
Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation
Funsho E Fakuade, Vanessa Steckmeister, Fitzwilliam Seibertz, et al.
Cardiovascular Research
|
May 24, 2021
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy
Felix Wiedmann, Christoph Beyersdorf, Xiao Bo Zhou, et al.
The Journal of Biological Chemistry
|
March 7, 2025
Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting Na<sub>V</sub>1.5, K<sub>V</sub>1.5, and K<sub>2</sub>P channels for atrial fibrillation
Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, et al.
Circulation Research
|
October 15, 2025
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial Fibrillation
Julius Ryan D Pronto, Fleur E Mason, Eva A Rog-Zielinska, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
European Heart Journal
|
January 7, 2017
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy
Constanze Schmidt, Felix Wiedmann, Xiao-Bo Zhou, et al.
Circulation
|
May 9, 2015
Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
Constanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Circulation
|
March 16, 2016
Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation"
Constanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Cardiovascular Research
|
June 11, 2020
Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation
Funsho E Fakuade, Vanessa Steckmeister, Fitzwilliam Seibertz, et al.
Cardiovascular Research
|
May 24, 2021
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy
Felix Wiedmann, Christoph Beyersdorf, Xiao Bo Zhou, et al.
The Journal of Biological Chemistry
|
March 7, 2025
Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting Na<sub>V</sub>1.5, K<sub>V</sub>1.5, and K<sub>2</sub>P channels for atrial fibrillation
Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, et al.
Circulation Research
|
October 15, 2025
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial Fibrillation
Julius Ryan D Pronto, Fleur E Mason, Eva A Rog-Zielinska, et al.
Page
of 6